Agape ATP Corporation (NASDAQ:ATPC) Sees Large Growth in Short Interest

Agape ATP Corporation (NASDAQ:ATPC) saw a large increase in short interest in the month of July. As of July 31st, there was short interest totaling 29,079 shares, an increase of 88.6% from the July 15th total of 15,420 shares. Based on an average daily volume of 3,579,723 shares, the days-to-cover ratio is presently 0.0 days. Approximately 3.0% of the shares of the company are short sold.

Agape ATP Stock Performance

Agape ATP stock traded down $0.01 during midday trading on Friday, hitting $2.49. 19,484 shares of the company’s stock were exchanged, compared to its average volume of 454,781. Agape ATP has a 52-week low of $1.72 and a 52-week high of $73.50. The stock has a 50-day moving average price of $2.82 and a two-hundred day moving average price of $2.81. The company has a market cap of $2.49 million, a P/E ratio of -1.87 and a beta of 0.38.

Agape ATP (NASDAQ:ATPC) last released its quarterly earnings results on Friday, August 14th. The company reported $0.15 earnings per share for the quarter. The firm had revenue of $0.01 million for the quarter. Agape ATP had a negative return on equity of 8.43% and a negative net margin of 125.89%.

Analysts Set New Price Targets

ATPC has been the subject of a number of analyst reports. Weiss Ratings restated a “sell (e+)” rating on shares of Agape ATP in a research report on Friday, May 22nd. Wall Street Zen raised shares of Agape ATP from a “sell” rating to a “hold” rating in a report on Monday, June 29th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has a consensus rating of “Sell”.

Institutional Investors Weigh In On Agape ATP

An institutional investor recently raised its position in Agape ATP stock. Citadel Advisors LLC grew its stake in Agape ATP Corporation (NASDAQ:ATPC) by 95.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 65,130 shares of the company’s stock after buying an additional 31,849 shares during the period. Citadel Advisors LLC owned approximately 0.13% of Agape ATP worth $82,000 at the end of the most recent reporting period. 0.01% of the stock is owned by institutional investors.

Agape ATP Company Profile

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.